ITALY: MgShell, a MedTech that aims to revolutionise the treatment of exudative maculopathy, announces the closing of a €500,000 investment round by Bios Line Holding, a company that invests in Life Sciences ventures, Club degli Investitori, one of the leading business angel groups in Italy, and Italian Angels for Biotech, the first Italian angel association exclusively dedicated to Life Sciences. The latter made the investment through the Ersel Group’s Simon Fiduciaria.